Pharmaocepidemology (PE) and adverse drug events (ADE): From identification to prevention

被引：0
|
作者：
Gilbert, A. [1 ]
Roughead, E. [1 ]
Peck, R. [2 ]
Killer, G. [2 ]
机构：
[1] Univ S Australia, Adelaide, SA 5001, Australia
[2] Dept Vet Affairs, Canberra, ACT, Australia
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
170
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [41] PREDICTIVE VALUE OF ALERT TRIGGERS FOR IDENTIFICATION OF DEVELOPING ADVERSE DRUG EVENTS
    Moore, C. R.
    Li, J.
    Hung, C.
    Downs, J.
    Nebeker, J. R.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 143 - 143
  • [42] Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events
    Roitmann, Eva
    Eriksson, Robert
    Brunak, Soren
    FRONTIERS IN PHYSIOLOGY, 2014, 5
  • [43] Prevention of Medication Errors in Hospitalized Patients: The Japan Adverse Drug Events Study
    Chihiro Noguchi
    Mio Sakuma
    Yoshinori Ohta
    David W. Bates
    Takeshi Morimoto
    Drug Safety, 2016, 39 : 1129 - 1137
  • [44] Root causes of adverse drug events in hospitals and artificial intelligence capabilities for prevention
    Gordo, Cristina
    Nunez-Cordoba, Jorge M.
    Mateo, Ricardo
    JOURNAL OF ADVANCED NURSING, 2021, 77 (07) : 3168 - 3175
  • [45] A Statistics-based Approach of Contextualization for Adverse Drug Events Detection and Prevention
    Chazard, Emmanuel
    Bernonville, Stephanie
    Ficheur, Gregoire
    Beuscart, Regis
    QUALITY OF LIFE THROUGH QUALITY OF INFORMATION, 2012, 180 : 766 - 770
  • [46] Potential adverse drug events in family planning clinics - Whose responsibility for prevention?
    Gbolade, BA
    BRITISH JOURNAL OF FAMILY PLANNING, 1996, 22 (03): : 161 - 161
  • [47] Prevention of Adverse Drug Events in Hospitalised Older Patients: A Randomised controlled Trial
    Connor, Marie O.
    O'Sullivan, David
    Gallagher, Paul
    Byrne, Stephen
    Eustace, Joseph
    O'Mahony, Denis
    IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : S222 - S223
  • [48] Potential risks and prevention, part 4: Reports of significant adverse drug events
    Kelly, WN
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (15) : 1406 - 1412
  • [49] Prevention of Medication Errors in Hospitalized Patients: The Japan Adverse Drug Events Study
    Noguchi, Chihiro
    Sakuma, Mio
    Ohta, Yoshinori
    Bates, David W.
    Morimoto, Takeshi
    DRUG SAFETY, 2016, 39 (11) : 1129 - 1137
  • [50] Pharmacists preventing opioid-induced adverse drug events: Case-control versus voluntary ADE reporting
    Raymo, L. L.
    Wolowich, W. R.
    Camejo, M.
    Rodriguez, J. C.
    Prieto, M. L.
    Connors, J. T.
    Duenas, S. R.
    Hawkins-Locke, C.
    CLINICAL TOXICOLOGY, 2008, 46 (07) : 603 - 603
12345